Data from the Swedish Rheumatology Quality register (2716 RA pts) shows that biologic naive patients had longer drug survival. Men (HR 0.86) and MTX users (HR 0.85) were less likely to discontinue abatacept, https://t.co/Vhy3XtEg8R
Links:
Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and the…
http://bit.ly/3aD21LW
Jan-23-2020
